6-K/A

DIRECTOR/PDMR SHAREHOLDING - CORRECTION

Company: Indivior Pharmaceuticals, Inc.
Filed: January 25, 2024
Period of Report: January 25, 2024
Accession Number: 0001654954-24-000918

View Document ↗ View on SEC.gov ↗